These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27866686)

  • 1. Size, Loading Efficiency, and Cytotoxicity of Albumin-Loaded Chitosan Nanoparticles: An Artificial Neural Networks Study.
    Baharifar H; Amani A
    J Pharm Sci; 2017 Jan; 106(1):411-417. PubMed ID: 27866686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
    Gan Q; Wang T
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
    Dionísio M; Cordeiro C; Remuñán-López C; Seijo B; Rosa da Costa AM; Grenha A
    Eur J Pharm Sci; 2013 Sep; 50(1):102-13. PubMed ID: 23624352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S; Zhang X; Teng D; Wang Z; Li C
    Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembled Reduced Albumin and Glycol Chitosan Nanoparticles for Paclitaxel Delivery.
    Razi MA; Wakabayashi R; Goto M; Kamiya N
    Langmuir; 2019 Feb; 35(7):2610-2618. PubMed ID: 30673276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of chitosan/streptokinase nanoparticles as a function of size: An artificial neural networks study.
    Baharifar H; Amani A
    Nanomedicine; 2016 Jan; 12(1):171-80. PubMed ID: 26409193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
    Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G
    Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of N-trimethyl chitosan-protein nanoparticles intended for vaccine delivery.
    Li XY; Li X; Kong XY; Shi S; Guo G; Zhang J; Luo F; Zhao X; Wei YQ; Qian ZY; Yang L
    J Nanosci Nanotechnol; 2010 Aug; 10(8):4850-8. PubMed ID: 21125819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile.
    Nafee N; Schneider M; Schaefer UF; Lehr CM
    Int J Pharm; 2009 Nov; 381(2):130-9. PubMed ID: 19450671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vivo evaluation of chitosan nanoparticles for the oral delivery of albumin.
    Nashaat D; Elsabahy M; El-Sherif T; Hamad MA; El-Gindy GA; Ibrahim EH
    Pharm Dev Technol; 2019 Mar; 24(3):329-337. PubMed ID: 29781756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chitosan salts and molecular weight on a nanoparticulate carrier for therapeutic protein.
    Luangtana-anan M; Opanasopit P; Ngawhirunpat T; Nunthanid J; Sriamornsak P; Limmatvapirat S; Lim LY
    Pharm Dev Technol; 2005; 10(2):189-96. PubMed ID: 15926667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of processing parameters on particle size of ultrasound prepared chitosan nanoparticles: an Artificial Neural Networks Study.
    Esmaeilzadeh-Gharedaghi E; Faramarzi MA; Amini MA; Rouholamini Najafabadi A; Rezayat SM; Amani A
    Pharm Dev Technol; 2012; 17(5):638-47. PubMed ID: 22681416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery.
    Gao P; Xia G; Bao Z; Feng C; Cheng X; Kong M; Liu Y; Chen X
    Int J Biol Macromol; 2016 Oct; 91():716-23. PubMed ID: 27287772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
    Arif M; Raja MA; Zeenat S; Chi Z; Liu C
    J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle formation by using shellac and chitosan for a protein delivery system.
    Kraisit P; Limmatvapirat S; Nunthanid J; Sriamornsak P; Luangtana-anan M
    Pharm Dev Technol; 2013; 18(3):686-93. PubMed ID: 22568768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
    J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.